Swedish Researchers Develop Blood Test Detecting Cancer DNA at Lower Concentrations
Researchers and companies have unveiled several distinct advances in blood-based cancer detection, targeting pancreatic, lung, and general cancer DNA analysis. These include a Swedish method lowering the detectable cancer DNA threshold to 5%, a single-molecule enzyme platform detecting early-stage pancreatic cancer with 75% sensitivity, and a proteomic lung cancer test showing 83% sensitivity for Stage I disease. Together, these developments signal a broadening push toward liquid biopsy as a practical clinical tool for catching cancers earlier.
A cluster of new studies and announcements highlights rapid progress in liquid biopsy technology for early cancer detection. Researchers at Chalmers University of Technology and the University of Gothenburg developed a method capable of analyzing blood samples with as little as 5% cancer DNA, significantly improving on the current 15–20% threshold and potentially enabling earlier monitoring of tumor progression. Separately, a preprint published on bioRxiv describes a single-molecule enzyme activity profiling (SEAP) platform that detected pancreatic ductal adenocarcinoma (PDAC) across stages I–IV with 95.5% specificity and 75% sensitivity across 690 blood samples from multiple hospitals, including 74.2% sensitivity for early-stage disease. For lung cancer, PrognomiQ reported early real-world results for its ProVue Lung test, which achieved 83% sensitivity for Stage I disease and 89% overall sensitivity in a cohort of 78 high-risk adults, though specificity was only 54%. The Economist also reported on emerging techniques for predicting and preventing lung cancer, underscoring the broader momentum in this field. Collectively, these advances address a critical gap: most cancers are currently diagnosed at advanced stages when treatment options are more limited and outcomes worse. While promising, several of these approaches remain in early validation phases and have not yet been approved for routine clinical use.
What's missing
The Swedish cancer DNA threshold study (Source 1) does not specify which cancer types were tested, the sample sizes involved, or whether the method has been validated in clinical cohorts. The SEAP pancreatic cancer platform (Source 2) is a preprint and has not yet undergone peer review; the study also does not address false-positive rates in non-cancer disease populations such as pancreatitis. The ProVue Lung test results (Source 3) come from a company press release based on a small cohort of 78 patients, with low specificity (54%) not yet explained or contextualized, and the study has not been published in a peer-reviewed journal. The Economist article's specific findings and methodology could not be assessed due to insufficient content provided.
What different sources said
- Medical XpressCenter
Blood test method detects cancer DNA at 5%, down from 15%-20% threshold
- bioRxivCenter
Early detection of pancreatic ductal adenocarcinoma by single-molecule profiling of pancreatic enzyme activities
- The EconomistCenter
New techniques can predict and prevent lung cancer
- Clinical Lab ProductsCenter
Blood Test Shows High Sensitivity for Early-Stage Lung Cancer Detection
Related
Chicago Woman's Five-Year Symptom Journey Leads to Rare Brain Tumor Diagnosis
Melony Aponte, 26, was diagnosed with a 4.5-centimeter acoustic neuroma after five years of symptoms she attributed to stress, COVID-19, and aging. The rare, noncancerous tumor—affecting roughly one in 100,000 people—had grown large enough to compress her hearing and balance nerve before it was identified via MRI in March 2025. Her case highlights how acoustic neuroma symptoms can mimic common conditions, potentially delaying diagnosis for years.
Study Finds Aging Shifts Walking Strategy Toward Stability at the Cost of Efficiency
A new study from Flinders University and the University of Canberra found that as people age, their bodies adopt a 'safety-first' walking pattern that prioritizes balance over efficient movement. Researchers analyzed gait data from 107 healthy adults aged 26 to 86, identifying increased ankle muscle co-contraction and reduced push-off power as key age-related changes. The findings suggest that fall prevention programs should target balance and coordination, not just muscle strength.
Tick Populations Surge in Urban Areas Across Northeast
Experts across the northeastern United States and Canada are warning of an unusually early and widespread tick season, with disease-carrying ticks increasingly found in urban parks and green spaces. Lyme disease cases in Canada reached a record 7,105 in 2025, up from 5,809 the previous year, while U.S. cities including Philadelphia, Pittsburgh, Washington D.C., and New York are reporting rising tick activity. The expansion poses a public health challenge because urban residents are less likely to take tick-bite precautions than those in rural areas.